ATOPALM Hemorrhoidal

Product NDC: 51141-0230
11-digit product format: 511410230
Labeler code: 51141
Product ID: 51141-0230_d3cf0652-d915-4d32-8f38-dc3df1283b2e
Type: HUMAN OTC DRUG
Nonproprietary name: MINERAL OIL, PETROLATUM, PHENYLEPHRINE HYDROCHLORIDE
Dosage form: OINTMENT
Route: TOPICAL
Labeler: NeoPharm USA
Application: part346
Marketing category: OTC MONOGRAPH FINAL
Marketing start: 2012-07-18
Marketing end: 0000-00-00
Substance: MINERAL OIL; PETROLATUM; PHENYLEPHRINE HYDROCHLORIDE
Active strength: 14 g/100g; g/100g; g/100g
NDC exclude flag: E
Listing certified through: 2017-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 2 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Reporting period	Source date
excluded product	product	51141-0230		I	Inactivated by FDA		2026-10-15
excluded package	package	51141-0230	51141-0230-2	I	Inactivated by FDA		2026-10-15

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 44 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	51141-0230-2	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	51141-0230-2	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	51141-0230-2	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	51141-0230-2	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	51141-0230-2	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	51141-0230-2	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	51141-0230-2	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	51141-0230-2	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	51141-0230-2	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded product	product		`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	51141-0230-2	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded product	product		`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	51141-0230-2	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded product	product		`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	51141-0230-2	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded product	product		`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded package	package	51141-0230-2	`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded product	product		`834df4deac94…`	`adcc014656a3…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded package	package	51141-0230-2	`834df4deac94…`	`adcc014656a3…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded product	product		`1332a3947898…`	`d4bfe170f9cd…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded package	package	51141-0230-2	`1332a3947898…`	`d4bfe170f9cd…`
2022-08-30 03:57 UTC · source 2022-08-29	excluded product	product		`fb8cb913e6d1…`	`eb8c232b6be0…`
2022-08-30 03:57 UTC · source 2022-08-29	excluded package	package	51141-0230-2	`fb8cb913e6d1…`	`eb8c232b6be0…`
2022-04-09 23:13 UTC · source 2022-04-08	excluded product	product		`86f5da6cb304…`	`a595104c45d7…`
2022-04-09 23:13 UTC · source 2022-04-08	excluded package	package	51141-0230-2	`86f5da6cb304…`	`a595104c45d7…`
2022-04-04 05:40 UTC · source 2022-04-01	excluded product	product		`bd6a592717d7…`	`303034d00443…`
2022-04-04 05:40 UTC · source 2022-04-01	excluded package	package	51141-0230-2	`bd6a592717d7…`	`303034d00443…`
2021-12-27 23:28 UTC · source 2021-12-27	excluded product	product		`8dfbde2a14a4…`	`c9ff85d89658…`
2021-12-27 23:28 UTC · source 2021-12-27	excluded package	package	51141-0230-2	`8dfbde2a14a4…`	`c9ff85d89658…`
2020-12-18 03:04 UTC · source 2020-12-17	excluded product	product		`e2bbac7714bc…`	`27bdfed8d636…`
2020-12-18 03:04 UTC · source 2020-12-17	excluded package	package	51141-0230-2	`e2bbac7714bc…`	`27bdfed8d636…`
2020-06-10 20:45 UTC · source 2020-06-10	excluded product	product		`9bebd1f3094a…`	`5416666fcb17…`
2020-06-10 20:45 UTC · source 2020-06-10	excluded package	package	51141-0230-2	`9bebd1f3094a…`	`5416666fcb17…`
2019-12-08 06:16 UTC · source 2019-12-05	excluded product	product		`110d247fa046…`	`a55b01930146…`
2019-12-08 06:16 UTC · source 2019-12-05	excluded package	package	51141-0230-2	`110d247fa046…`	`a55b01930146…`

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
e4e263da-1c53-440f-bb80-b7a575843b5a	Product name	1	20260313
d2168cac-a261-415a-9c78-3522859fa720	Product name	3	20251124
05a8cdd1-eeb8-409e-b938-0778225eca7d	Product name	4	20250221
e5b5c132-b15d-435b-9faa-2f74e5cadcf9	Product name	8	20250220
f489e8f3-5c9e-4818-b539-a73587edcfc7	Product name	2	20240229
0f7ae452-206d-4fc4-868d-56fc47074084	Product name	1	20231011
b5abe2e3-39a1-43eb-9bff-f3c1653fe3df	Product name	2	20190930
e0b6c8be-f2bd-9f86-a9fc-3ed56ffaa814	Product name	3	20150910
42f3c020-f1b3-89bc-7bdc-e1f10e680485	Product name	1	20140508
e949165d-714d-e548-2b76-0cb5def16f30	Product name	1	20140508

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
51141-0230-2	2019-11-13	C162847	48780-1	97449f38-bc69-f6ea-e053-dbdaa90aa703	ATOPALM Hemorrhoidal Ointment

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
51141-0230-2	ATOPALM Hemorrhoidal	1 in 1 CARTON	OINTMENT	1		2
51141-0230-2	ATOPALM Hemorrhoidal	56 g in 1 TUBE	OINTMENT	56		2

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
MINERAL OIL	ACTIVE INGREDIENT	T5L8T28FGP	ATOPALM HEMORRHOIDAL (MINERAL OIL, PETROLATUM, PHENYLEPHRINE HYDROCHLORIDE) OINTMENT [NEOPHARM USA]	2
PETROLATUM	ACTIVE INGREDIENT	4T6H12BN9U	ATOPALM HEMORRHOIDAL (MINERAL OIL, PETROLATUM, PHENYLEPHRINE HYDROCHLORIDE) OINTMENT [NEOPHARM USA]	2
PHENYLEPHRINE HYDROCHLORIDE	ACTIVE INGREDIENT	04JA59TNSJ	ATOPALM HEMORRHOIDAL (MINERAL OIL, PETROLATUM, PHENYLEPHRINE HYDROCHLORIDE) OINTMENT [NEOPHARM USA]	2
MINERAL OIL	ACTIVE MOIETY	T5L8T28FGP	ATOPALM HEMORRHOIDAL (MINERAL OIL, PETROLATUM, PHENYLEPHRINE HYDROCHLORIDE) OINTMENT [NEOPHARM USA]	2
PETROLATUM	ACTIVE MOIETY	4T6H12BN9U	ATOPALM HEMORRHOIDAL (MINERAL OIL, PETROLATUM, PHENYLEPHRINE HYDROCHLORIDE) OINTMENT [NEOPHARM USA]	2
PHENYLEPHRINE	ACTIVE MOIETY	1WS297W6MV	ATOPALM HEMORRHOIDAL (MINERAL OIL, PETROLATUM, PHENYLEPHRINE HYDROCHLORIDE) OINTMENT [NEOPHARM USA]	2
.ALPHA.-TOCOPHEROL ACETATE	INACTIVE INGREDIENT	9E8X80D2L0	ATOPALM HEMORRHOIDAL (MINERAL OIL, PETROLATUM, PHENYLEPHRINE HYDROCHLORIDE) OINTMENT [NEOPHARM USA]	2
BUTYLATED HYDROXYTOLUENE	INACTIVE INGREDIENT	1P9D0Z171K	ATOPALM HEMORRHOIDAL (MINERAL OIL, PETROLATUM, PHENYLEPHRINE HYDROCHLORIDE) OINTMENT [NEOPHARM USA]	2
CHOLESTEROL	INACTIVE INGREDIENT	97C5T2UQ7J	ATOPALM HEMORRHOIDAL (MINERAL OIL, PETROLATUM, PHENYLEPHRINE HYDROCHLORIDE) OINTMENT [NEOPHARM USA]	2
COD LIVER OIL	INACTIVE INGREDIENT	BBL281NWFG	ATOPALM HEMORRHOIDAL (MINERAL OIL, PETROLATUM, PHENYLEPHRINE HYDROCHLORIDE) OINTMENT [NEOPHARM USA]	2
GLYCERIN	INACTIVE INGREDIENT	PDC6A3C0OX	ATOPALM HEMORRHOIDAL (MINERAL OIL, PETROLATUM, PHENYLEPHRINE HYDROCHLORIDE) OINTMENT [NEOPHARM USA]	2
LANOLIN	INACTIVE INGREDIENT	7EV65EAW6H	ATOPALM HEMORRHOIDAL (MINERAL OIL, PETROLATUM, PHENYLEPHRINE HYDROCHLORIDE) OINTMENT [NEOPHARM USA]	2
METHYLPARABEN	INACTIVE INGREDIENT	A2I8C7HI9T	ATOPALM HEMORRHOIDAL (MINERAL OIL, PETROLATUM, PHENYLEPHRINE HYDROCHLORIDE) OINTMENT [NEOPHARM USA]	2
MYRISTOYL/PALMITOYL OXOSTEARAMIDE/ARACHAMIDE MEA	INACTIVE INGREDIENT	1211AIM8G7	ATOPALM HEMORRHOIDAL (MINERAL OIL, PETROLATUM, PHENYLEPHRINE HYDROCHLORIDE) OINTMENT [NEOPHARM USA]	2
PARAFFIN	INACTIVE INGREDIENT	I9O0E3H2ZE	ATOPALM HEMORRHOIDAL (MINERAL OIL, PETROLATUM, PHENYLEPHRINE HYDROCHLORIDE) OINTMENT [NEOPHARM USA]	2
PROPYLPARABEN	INACTIVE INGREDIENT	Z8IX2SC1OH	ATOPALM HEMORRHOIDAL (MINERAL OIL, PETROLATUM, PHENYLEPHRINE HYDROCHLORIDE) OINTMENT [NEOPHARM USA]	2
SODIUM BENZOATE	INACTIVE INGREDIENT	OJ245FE5EU	ATOPALM HEMORRHOIDAL (MINERAL OIL, PETROLATUM, PHENYLEPHRINE HYDROCHLORIDE) OINTMENT [NEOPHARM USA]	2
SQUALANE	INACTIVE INGREDIENT	GW89575KF9	ATOPALM HEMORRHOIDAL (MINERAL OIL, PETROLATUM, PHENYLEPHRINE HYDROCHLORIDE) OINTMENT [NEOPHARM USA]	2
STEARIC ACID	INACTIVE INGREDIENT	4ELV7Z65AP	ATOPALM HEMORRHOIDAL (MINERAL OIL, PETROLATUM, PHENYLEPHRINE HYDROCHLORIDE) OINTMENT [NEOPHARM USA]	2
THYME OIL	INACTIVE INGREDIENT	2UK410MY6B	ATOPALM HEMORRHOIDAL (MINERAL OIL, PETROLATUM, PHENYLEPHRINE HYDROCHLORIDE) OINTMENT [NEOPHARM USA]	2
WATER	INACTIVE INGREDIENT	059QF0KO0R	ATOPALM HEMORRHOIDAL (MINERAL OIL, PETROLATUM, PHENYLEPHRINE HYDROCHLORIDE) OINTMENT [NEOPHARM USA]	2

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
51141-0230	ATOPALM HEMORRHOIDAL (MINERAL OIL, PETROLATUM, PHENYLEPHRINE HYDROCHLORIDE) OINTMENT [NEOPHARM USA]	2	Legacy NDC, 2 package rows	20120719_7983ad30-ee7f-49dc-8ffa-1457d21e590e.zip

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
T5L8T28FGP	MINERAL OIL	8042-47-5	MINERAL OIL
4T6H12BN9U	PETROLATUM	8009-03-8	PETROLATUM
04JA59TNSJ	PHENYLEPHRINE HYDROCHLORIDE	61-76-7	PHENYLEPHRINE HYDROCHLORIDE

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
1359113	ATOPALM Hemorrhoidal 14 % / 71.9 % / 0.25 % Rectal Ointment	PSN	7983ad30-ee7f-49dc-8ffa-1457d21e590e	2
1313818	mineral oil 14 % / petrolatum 71.9 % / phenylephrine HCl 0.25 % Rectal Ointment	PSN	7983ad30-ee7f-49dc-8ffa-1457d21e590e	2
1359113	mineral oil 0.14 MG/MG / petrolatum 0.719 MG/MG / phenylephrine hydrochloride 0.0025 MG/MG Rectal Ointment [Atopalm Hemorrhoidal]	SBD	7983ad30-ee7f-49dc-8ffa-1457d21e590e	2
1313818	mineral oil 0.14 MG/MG / petrolatum 0.719 MG/MG / phenylephrine hydrochloride 0.0025 MG/MG Rectal Ointment	SCD	7983ad30-ee7f-49dc-8ffa-1457d21e590e	2
1359113	Atopalm Hemorrhoidal (mineral oil 14 % / petrolatum 71.9 % / phenylephrine hydrochloride 0.25 % ) Rectal Ointment	SY	7983ad30-ee7f-49dc-8ffa-1457d21e590e	2
1313818	mineral oil 14 % / petrolatum 71.9 % / phenylephrine hydrochloride 0.25 % Rectal Ointment	SY	7983ad30-ee7f-49dc-8ffa-1457d21e590e	2

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Status
51141-0230-2	51141023002	1 in 1 CARTON	Historical

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
ATOPALM Hemorrhoidal Ointment	NeoPharm USA \| NeoPharm Co., Ltd.	2012-07-18	HUMAN OTC DRUG LABEL	2